chip seq Search Results


93
Zymo Research sequencing
Sequencing, supplied by Zymo Research, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq/pm34021049-180-2-27?v=Zymo+Research
Average 93 stars, based on 1 article reviews
sequencing - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

96
Complete Genomics Inc stomics mini chips
Stomics Mini Chips, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq/bio_rxiv__2024__11__18__624127-159-7-7?v=Complete+Genomics+Inc
Average 96 stars, based on 1 article reviews
stomics mini chips - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

93
Rockland Immunochemicals rabbit anti histone γh2avd ps137
Rabbit Anti Histone γh2avd Ps137, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq/bio_rxiv__2025__05__16__654569-87-11-16?v=Rockland+Immunochemicals
Average 93 stars, based on 1 article reviews
rabbit anti histone γh2avd ps137 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

92
Rockland Immunochemicals chip assays
FIGURE 8. In situ binding of RREB-1 or HDAC1 to the HLA-G pro- moter in a repressive and active-type chromatin. A and B, <t>ChIP</t> performed with JEG-3 (HLA-G ) and M8 (HLA-G ) cells using anti-RREB-1 and anti-HDAC1 Abs on distal and proximal promoter regions (A) Abs target- ing RNA polymerase II <t>(RNApolII),</t> <t>acetylated</t> histone H3 (AcH3), and phosphorylated histone H3 (AcH3 P) on proximal promoter region (B). Immunoprecipitated HLA-G promoter regions are analyzed on agarose gels by semiquantitative HLA-G-specific PCRs targeting proximal and distal HLA-G promoter. Input chromatin (Input) used as PCR control and IgG () are shown. The absence of RREB-1 and HDAC1 binding observed in JEG-3 cells and the absence of RNA polymerase II, acetylated histone H3, and phosphorylated histone H3 binding in M8 cells validate the specificity of Abs used in ChIP assays.
Chip Assays, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq/pm19890057-127-0-11?v=Rockland+Immunochemicals
Average 92 stars, based on 1 article reviews
chip assays - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

86
Epigenomics ag chip seq data
Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as <t>histone</t> <t>ChIP-seq</t> or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.
Chip Seq Data, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq/pmc11379467-68-10-14?v=Epigenomics+ag
Average 86 stars, based on 1 article reviews
chip seq data - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

96
Complete Genomics Inc modification
Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as <t>histone</t> <t>ChIP-seq</t> or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.
Modification, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq/pm40904198-237-20-21?v=Complete+Genomics+Inc
Average 96 stars, based on 1 article reviews
modification - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

96
Complete Genomics Inc stereo seq chips
Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as <t>histone</t> <t>ChIP-seq</t> or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.
Stereo Seq Chips, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq/bio_rxiv__2024__02__28__582639-77-8-10?v=Complete+Genomics+Inc
Average 96 stars, based on 1 article reviews
stereo seq chips - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

86
Chrom Tech gm12878 ctcf chip seq encff355cyx
Paired End Example for <t>GM12878</t> Chrom-Sig results for all paired-end datasets from GM12878 cell-line, visualized in the genome browser. CTCF Motif: CTCF binding sites with orientation. Original: Bedgraph file generated directly from input BAM/bed file. SICER peaks: Bed file result of running SICER algorithm on the original bedgraph file. Chrom-Sig FDR 0.1 pass: pass bedgraph generated from original bedgraph by Chrom-Sig (percentage refers to how many reads were retained by Chrom-Sig result from original bedgraph). SICER peaks (below Chrom-Sig FDR 0.1 pass): Bed file from SICER algorithm run on pass-pileup bed generated by Chrom-Sig. ChromHMM: Chromatin states.
Gm12878 Ctcf Chip Seq Encff355cyx, supplied by Chrom Tech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq/bio_rxiv__2025__08__12__670000-105-4-14?v=Chrom+Tech
Average 86 stars, based on 1 article reviews
gm12878 ctcf chip seq encff355cyx - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

90
Alphamed INC encode chip-seq data
Paired End Example for <t>GM12878</t> Chrom-Sig results for all paired-end datasets from GM12878 cell-line, visualized in the genome browser. CTCF Motif: CTCF binding sites with orientation. Original: Bedgraph file generated directly from input BAM/bed file. SICER peaks: Bed file result of running SICER algorithm on the original bedgraph file. Chrom-Sig FDR 0.1 pass: pass bedgraph generated from original bedgraph by Chrom-Sig (percentage refers to how many reads were retained by Chrom-Sig result from original bedgraph). SICER peaks (below Chrom-Sig FDR 0.1 pass): Bed file from SICER algorithm run on pass-pileup bed generated by Chrom-Sig. ChromHMM: Chromatin states.
Encode Chip Seq Data, supplied by Alphamed INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq/pm27090862-116-3-20?v=Alphamed+INC
Average 90 stars, based on 1 article reviews
encode chip-seq data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Epigenomics ag histone chip-seq data spanning monocytes e029
Paired End Example for <t>GM12878</t> Chrom-Sig results for all paired-end datasets from GM12878 cell-line, visualized in the genome browser. CTCF Motif: CTCF binding sites with orientation. Original: Bedgraph file generated directly from input BAM/bed file. SICER peaks: Bed file result of running SICER algorithm on the original bedgraph file. Chrom-Sig FDR 0.1 pass: pass bedgraph generated from original bedgraph by Chrom-Sig (percentage refers to how many reads were retained by Chrom-Sig result from original bedgraph). SICER peaks (below Chrom-Sig FDR 0.1 pass): Bed file from SICER algorithm run on pass-pileup bed generated by Chrom-Sig. ChromHMM: Chromatin states.
Histone Chip Seq Data Spanning Monocytes E029, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq/pmc05870713-104-6-21?v=Epigenomics+ag
Average 90 stars, based on 1 article reviews
histone chip-seq data spanning monocytes e029 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
STARR Life Sciences chip-starr-seq
Paired End Example for <t>GM12878</t> Chrom-Sig results for all paired-end datasets from GM12878 cell-line, visualized in the genome browser. CTCF Motif: CTCF binding sites with orientation. Original: Bedgraph file generated directly from input BAM/bed file. SICER peaks: Bed file result of running SICER algorithm on the original bedgraph file. Chrom-Sig FDR 0.1 pass: pass bedgraph generated from original bedgraph by Chrom-Sig (percentage refers to how many reads were retained by Chrom-Sig result from original bedgraph). SICER peaks (below Chrom-Sig FDR 0.1 pass): Bed file from SICER algorithm run on pass-pileup bed generated by Chrom-Sig. ChromHMM: Chromatin states.
Chip Starr Seq, supplied by STARR Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq/pm30447332-305-14-17?v=STARR+Life+Sciences
Average 90 stars, based on 1 article reviews
chip-starr-seq - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
DIAGENODE DIAGNOSTICS ideal chip-seq kit transcription factors kit
Reagents and tools table
Ideal Chip Seq Kit Transcription Factors Kit, supplied by DIAGENODE DIAGNOSTICS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq/pmc11628624-101-0-8?v=DIAGENODE+DIAGNOSTICS
Average 90 stars, based on 1 article reviews
ideal chip-seq kit transcription factors kit - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


FIGURE 8. In situ binding of RREB-1 or HDAC1 to the HLA-G pro- moter in a repressive and active-type chromatin. A and B, ChIP performed with JEG-3 (HLA-G ) and M8 (HLA-G ) cells using anti-RREB-1 and anti-HDAC1 Abs on distal and proximal promoter regions (A) Abs target- ing RNA polymerase II (RNApolII), acetylated histone H3 (AcH3), and phosphorylated histone H3 (AcH3 P) on proximal promoter region (B). Immunoprecipitated HLA-G promoter regions are analyzed on agarose gels by semiquantitative HLA-G-specific PCRs targeting proximal and distal HLA-G promoter. Input chromatin (Input) used as PCR control and IgG () are shown. The absence of RREB-1 and HDAC1 binding observed in JEG-3 cells and the absence of RNA polymerase II, acetylated histone H3, and phosphorylated histone H3 binding in M8 cells validate the specificity of Abs used in ChIP assays.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: RREB-1 is a transcriptional repressor of HLA-G.

doi: 10.4049/jimmunol.0902053

Figure Lengend Snippet: FIGURE 8. In situ binding of RREB-1 or HDAC1 to the HLA-G pro- moter in a repressive and active-type chromatin. A and B, ChIP performed with JEG-3 (HLA-G ) and M8 (HLA-G ) cells using anti-RREB-1 and anti-HDAC1 Abs on distal and proximal promoter regions (A) Abs target- ing RNA polymerase II (RNApolII), acetylated histone H3 (AcH3), and phosphorylated histone H3 (AcH3 P) on proximal promoter region (B). Immunoprecipitated HLA-G promoter regions are analyzed on agarose gels by semiquantitative HLA-G-specific PCRs targeting proximal and distal HLA-G promoter. Input chromatin (Input) used as PCR control and IgG () are shown. The absence of RREB-1 and HDAC1 binding observed in JEG-3 cells and the absence of RNA polymerase II, acetylated histone H3, and phosphorylated histone H3 binding in M8 cells validate the specificity of Abs used in ChIP assays.

Article Snippet: ChIP assays were performed as previously described (51) using antiRREB-1 from Rockland; anti-acetylated histone H3 (06-599) and antiphosphorylated Ser10 histone H3 (07-081) from Upstate Biotechnology Associates; and anti-RNApolII (C-21) and anti-HDAC1 (H-51) from Santa Cruz Biotechnology.

Techniques: In Situ, Binding Assay, Immunoprecipitation, Control

Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as histone ChIP-seq or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.

Journal: Bioinformatics

Article Title: Deep5hmC: predicting genome-wide 5-hydroxymethylcytosine landscape via a multimodal deep learning model

doi: 10.1093/bioinformatics/btae528

Figure Lengend Snippet: Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as histone ChIP-seq or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.

Article Snippet: For “Human Tissues,” we carefully select aligned bed files of ChIP-seq data from Roadmap Epigenomics by ensuring a match between ChIP-seq data and 5hmC-seq data based on tissue type.

Techniques: Derivative Assay, ChIP-sequencing, Modification, Genome Wide, Control, Sequencing, Labeling, Expressing

Distribution pattern of histone modification around 5hmC peaks. EB 5hmC peaks are collected from “Forebrain Organoid” 5hmC-seq data and ChIP-seq data in “Brain Angular Gyrus” from seven histone marks are collected from Roadmap Epigenomics. Histone features are obtained and averaged in the neighborhood of all 5hmC peaks for the positive and negative sets, respectively. Specifically, histone features are created by segmenting an extended genomic region of 10 kb both upstream and downstream of each 5hmC peak into 41 1 kb windows with a sliding size of 500 bp and counting reads for each 1 kb windows. For each histone mark, the Kolmogorov–Smirnov test is performed to test the distribution difference of histone features between positive and negative 5hmC peaks and the P -value is reported.

Journal: Bioinformatics

Article Title: Deep5hmC: predicting genome-wide 5-hydroxymethylcytosine landscape via a multimodal deep learning model

doi: 10.1093/bioinformatics/btae528

Figure Lengend Snippet: Distribution pattern of histone modification around 5hmC peaks. EB 5hmC peaks are collected from “Forebrain Organoid” 5hmC-seq data and ChIP-seq data in “Brain Angular Gyrus” from seven histone marks are collected from Roadmap Epigenomics. Histone features are obtained and averaged in the neighborhood of all 5hmC peaks for the positive and negative sets, respectively. Specifically, histone features are created by segmenting an extended genomic region of 10 kb both upstream and downstream of each 5hmC peak into 41 1 kb windows with a sliding size of 500 bp and counting reads for each 1 kb windows. For each histone mark, the Kolmogorov–Smirnov test is performed to test the distribution difference of histone features between positive and negative 5hmC peaks and the P -value is reported.

Article Snippet: For “Human Tissues,” we carefully select aligned bed files of ChIP-seq data from Roadmap Epigenomics by ensuring a match between ChIP-seq data and 5hmC-seq data based on tissue type.

Techniques: Modification, ChIP-sequencing

Comparison of unimodal and multimodal Deep5hmC for predicting binary 5hmC modification sites. When using histone modification in the epigenetic modality, two unimodal models of Deep5hmC: Deep5hmC-Seq using only DNA sequence as the model input and Deep5hmC-His using only histone modification as the model input are compared to the default multimodal Deep5hmC-Seq+His using both DNA sequence and histone modification as the model input. 5hmC peaks from the EB stage “Forebrain Organoid” and two histone marks: H3K4me1 and H3K4me3 ChIP-seq data in all brain regions from Roadmap Epigenomics are used as the training set. ( A ) AUROC reported for three compared methods. ( B ) AUPRC reported three compared methods.

Journal: Bioinformatics

Article Title: Deep5hmC: predicting genome-wide 5-hydroxymethylcytosine landscape via a multimodal deep learning model

doi: 10.1093/bioinformatics/btae528

Figure Lengend Snippet: Comparison of unimodal and multimodal Deep5hmC for predicting binary 5hmC modification sites. When using histone modification in the epigenetic modality, two unimodal models of Deep5hmC: Deep5hmC-Seq using only DNA sequence as the model input and Deep5hmC-His using only histone modification as the model input are compared to the default multimodal Deep5hmC-Seq+His using both DNA sequence and histone modification as the model input. 5hmC peaks from the EB stage “Forebrain Organoid” and two histone marks: H3K4me1 and H3K4me3 ChIP-seq data in all brain regions from Roadmap Epigenomics are used as the training set. ( A ) AUROC reported for three compared methods. ( B ) AUPRC reported three compared methods.

Article Snippet: For “Human Tissues,” we carefully select aligned bed files of ChIP-seq data from Roadmap Epigenomics by ensuring a match between ChIP-seq data and 5hmC-seq data based on tissue type.

Techniques: Comparison, Modification, Sequencing, ChIP-sequencing

Paired End Example for GM12878 Chrom-Sig results for all paired-end datasets from GM12878 cell-line, visualized in the genome browser. CTCF Motif: CTCF binding sites with orientation. Original: Bedgraph file generated directly from input BAM/bed file. SICER peaks: Bed file result of running SICER algorithm on the original bedgraph file. Chrom-Sig FDR 0.1 pass: pass bedgraph generated from original bedgraph by Chrom-Sig (percentage refers to how many reads were retained by Chrom-Sig result from original bedgraph). SICER peaks (below Chrom-Sig FDR 0.1 pass): Bed file from SICER algorithm run on pass-pileup bed generated by Chrom-Sig. ChromHMM: Chromatin states.

Journal: bioRxiv

Article Title: Chrom-Sig: de-noising 1-dimensional genomic profiles by signal processing methods

doi: 10.1101/2025.08.12.670000

Figure Lengend Snippet: Paired End Example for GM12878 Chrom-Sig results for all paired-end datasets from GM12878 cell-line, visualized in the genome browser. CTCF Motif: CTCF binding sites with orientation. Original: Bedgraph file generated directly from input BAM/bed file. SICER peaks: Bed file result of running SICER algorithm on the original bedgraph file. Chrom-Sig FDR 0.1 pass: pass bedgraph generated from original bedgraph by Chrom-Sig (percentage refers to how many reads were retained by Chrom-Sig result from original bedgraph). SICER peaks (below Chrom-Sig FDR 0.1 pass): Bed file from SICER algorithm run on pass-pileup bed generated by Chrom-Sig. ChromHMM: Chromatin states.

Article Snippet: The analysis looks at GM12878 CTCF ChIP-seq ENCFF355CYX (36,269 peaks original, 24,872 peaks after Chrom-Sig) as well as GM12878 CTCF CUT&RUN replicates 4DNFI2G71DR4 (55,251 peaks original, 22,554 peaks after Chrom-Sig) and 4DNFI9U71IB4 (62,176 peaks original, 19,233 peaks after Chrom-Sig).

Techniques: Binding Assay, Generated

Single End Example Chrom-Sig results for all single-end datasets (all single-end data is from GM12878 cell-line), visualized in the genome browser. CTCF Motif: CTCF binding sites with orientation. Original: Bedgraph file generated directly from input BAM/bed file. SICER peaks: Bed file result of running SICER algorithm on the original bedgraph file. Chrom-Sig FDR 0.1 pass: pass bedgraph generated from original bedgraph by Chrom-Sig (percentage refers to how many reads were retained by Chrom-Sig result from original bedgraph). SICER peaks (below Chrom-Sig FDR 0.1 pass): Bed file from SICER algorithm run on pass-pileup bed generated by Chrom-Sig. ChromHMM: Chromatin states.

Journal: bioRxiv

Article Title: Chrom-Sig: de-noising 1-dimensional genomic profiles by signal processing methods

doi: 10.1101/2025.08.12.670000

Figure Lengend Snippet: Single End Example Chrom-Sig results for all single-end datasets (all single-end data is from GM12878 cell-line), visualized in the genome browser. CTCF Motif: CTCF binding sites with orientation. Original: Bedgraph file generated directly from input BAM/bed file. SICER peaks: Bed file result of running SICER algorithm on the original bedgraph file. Chrom-Sig FDR 0.1 pass: pass bedgraph generated from original bedgraph by Chrom-Sig (percentage refers to how many reads were retained by Chrom-Sig result from original bedgraph). SICER peaks (below Chrom-Sig FDR 0.1 pass): Bed file from SICER algorithm run on pass-pileup bed generated by Chrom-Sig. ChromHMM: Chromatin states.

Article Snippet: The analysis looks at GM12878 CTCF ChIP-seq ENCFF355CYX (36,269 peaks original, 24,872 peaks after Chrom-Sig) as well as GM12878 CTCF CUT&RUN replicates 4DNFI2G71DR4 (55,251 peaks original, 22,554 peaks after Chrom-Sig) and 4DNFI9U71IB4 (62,176 peaks original, 19,233 peaks after Chrom-Sig).

Techniques: Binding Assay, Generated

CTCF Motif Analyses a) Top enriched motifs, E-value, and matching motifs from MEME-Chip for GM12878 CUT&RUN CTCF 4DNFI2G71DR4 before and after Chrom-Sig. b) Comparison of CTCF motif precision between original data and Chrom-Sig with FDR 0.1 and 5000 pseudo-reads for GM12878 ChIP-seq CTCF ENCFF355CYX, GM12878 CUT&RUN CTCF 4DNFI2G71DR4 and 4DNFI9U71IB4.

Journal: bioRxiv

Article Title: Chrom-Sig: de-noising 1-dimensional genomic profiles by signal processing methods

doi: 10.1101/2025.08.12.670000

Figure Lengend Snippet: CTCF Motif Analyses a) Top enriched motifs, E-value, and matching motifs from MEME-Chip for GM12878 CUT&RUN CTCF 4DNFI2G71DR4 before and after Chrom-Sig. b) Comparison of CTCF motif precision between original data and Chrom-Sig with FDR 0.1 and 5000 pseudo-reads for GM12878 ChIP-seq CTCF ENCFF355CYX, GM12878 CUT&RUN CTCF 4DNFI2G71DR4 and 4DNFI9U71IB4.

Article Snippet: The analysis looks at GM12878 CTCF ChIP-seq ENCFF355CYX (36,269 peaks original, 24,872 peaks after Chrom-Sig) as well as GM12878 CTCF CUT&RUN replicates 4DNFI2G71DR4 (55,251 peaks original, 22,554 peaks after Chrom-Sig) and 4DNFI9U71IB4 (62,176 peaks original, 19,233 peaks after Chrom-Sig).

Techniques: Comparison, ChIP-sequencing

ChromHMM State Annotation Distribution Comparison of the distribution of chromHMM states between original data and Chrom-Sig with FDR 0.1 and 5000 pseudo-reads for K562 RNAPII ChIP-seq ENCFF480AJZ and ENCFF785OCU and GM12878 ATAC-seq ENCFF646NWY. The proportion of enhancer and promotor states increases when Chrom-Sig is applied to the data. Between K562 RNAPII ChIP-seq replicates there is an average of 12.3% higher distribution of enhancers and promotors (ENCFF480AJZ: 77% original vs 87.3% Chrom-Sig and ENCFF785OCU: 76.9% original vs 85.5% Chrom-Sig). In ATAC-seq data, the percentage of transcription and heterochromatin states drops from 28.9% to 12.6% after Chrom-Sig.

Journal: bioRxiv

Article Title: Chrom-Sig: de-noising 1-dimensional genomic profiles by signal processing methods

doi: 10.1101/2025.08.12.670000

Figure Lengend Snippet: ChromHMM State Annotation Distribution Comparison of the distribution of chromHMM states between original data and Chrom-Sig with FDR 0.1 and 5000 pseudo-reads for K562 RNAPII ChIP-seq ENCFF480AJZ and ENCFF785OCU and GM12878 ATAC-seq ENCFF646NWY. The proportion of enhancer and promotor states increases when Chrom-Sig is applied to the data. Between K562 RNAPII ChIP-seq replicates there is an average of 12.3% higher distribution of enhancers and promotors (ENCFF480AJZ: 77% original vs 87.3% Chrom-Sig and ENCFF785OCU: 76.9% original vs 85.5% Chrom-Sig). In ATAC-seq data, the percentage of transcription and heterochromatin states drops from 28.9% to 12.6% after Chrom-Sig.

Article Snippet: The analysis looks at GM12878 CTCF ChIP-seq ENCFF355CYX (36,269 peaks original, 24,872 peaks after Chrom-Sig) as well as GM12878 CTCF CUT&RUN replicates 4DNFI2G71DR4 (55,251 peaks original, 22,554 peaks after Chrom-Sig) and 4DNFI9U71IB4 (62,176 peaks original, 19,233 peaks after Chrom-Sig).

Techniques: Comparison, ChIP-sequencing

Reagents and tools table

Journal: EMBO Molecular Medicine

Article Title: Reciprocal inhibition of NOTCH and SOX2 shapes tumor cell plasticity and therapeutic escape in triple-negative breast cancer

doi: 10.1038/s44321-024-00161-8

Figure Lengend Snippet: Reagents and tools table

Article Snippet: iDeal ChIP-seq kit for Transcription Factors Kit , Diagenode , Cat#C01010170.

Techniques: Recombinant, Plasmid Preparation, Binding Assay, Polymer, SYBR Green Assay, Transfection, Protease Inhibitor, Reporter Assay, Gel Purification, Purification, Ligation, Software